Additional file 1 of Signature construction and molecular subtype identification based on liver-specific genes for prediction of prognosis, immune activity, and anti-cancer drug sensitivity in hepatocellular carcinoma

Additional file 1: Table S1. Clinical characters of the patients in TCGA-HCC dataset and ICGC-HCC dataset. Table S2. Expressional differences between HCC and normal liver tissues. Table S3. The LSGs differences among different HCC subtypes. Table S4. LSGs methylation comparisons among HCC subtypes. Table S5. LSGs expression comparisons among HCCs with different risk factors. Table S6. HCC subtype-specific genes. Table S7. Predication of HCC subtype with SVM method in TCGA-HCC dataset. Table S8. HCC subtype predication with SVM model in ICGC-HCC samples. Table S9. HCC subtype predication of TCGA-HCC samples with NTP method. Table S10. HCC subtype predication of ICGC-HCC samples with NTP method. Table S11. Prognostic effects of LSGs and HCC subtype-specific genes. Table S12. Hepatocyte subcluster proportions in different tissues. Table S13. The correlations of the key genes with the IC50s of anti-cancer drugs in HCC cell lines.